Our lab is equipped with advanced electrospinning systems to fabricate nanofibers for drug delivery and biomedical applications. This technique enables the production of ultrafine fibers with high surface area-to-volume ratio, tunable porosity, and the ability to incorporate a wide range of therapeutic agents. We specialize in developing customized nanofiber-based platforms for controlled drug release, wound healing, tissue regeneration, and implantable delivery systems. 

Our dedicated cell culture lab supports in vitro evaluation of drug-loaded nanofiber systems and other biomedical formulations. Equipped with biosafety cabinets, CO₂ incubators, and essential aseptic tools, we maintain a range of mammalian cell lines for cytotoxicity, biocompatibility, and cellular uptake studies. This facility enables preclinical screening of novel drug delivery platforms under controlled, sterile conditions. 

Our lab utilizes an ultrasonic probe sonicator for the efficient dispersion, emulsification, and size reduction of nanoparticles and polymer solutions. This high-intensity sonication system is essential for preparing stable nanoemulsions, drug-polymer blends, and homogeneous suspensions prior to electrospinning or encapsulation. It plays a critical role in enhancing formulation uniformity and reproducibility.